AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2022
Apr 30, 2022
31676_dirs_2022-04-29_136c11a2-0129-4428-968c-86cf963f3e54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2022-04-27
Reporting Person: HAUGHEY THOMAS (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-27 | Common Stock | A | 10049 | — | Acquired | 40251 | Direct |
Footnotes
F1: Represents a restricted stock award that will vest in full on April 27, 2023.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3